BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 15078345)

  • 1. Juvenile xanthogranuloma associated with neurofibromatosis 1: 14 patients without evidence of hematologic malignancies.
    Cambiaghi S; Restano L; Caputo R
    Pediatr Dermatol; 2004; 21(2):97-101. PubMed ID: 15078345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile xanthogranuloma in a child with previously unsuspected neurofibromatosis type 1 and juvenile myelomonocytic leukemia.
    Raygada M; Arthur DC; Wayne AS; Rennert OM; Toretsky JA; Stratakis CA
    Pediatr Blood Cancer; 2010 Jan; 54(1):173-5. PubMed ID: 19785027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of juvenile xanthogranuloma with juvenile myeloid leukemia.
    Cooper PH; Frierson HF; Kayne AL; Sabio H
    Arch Dermatol; 1984 Mar; 120(3):371-5. PubMed ID: 6422862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Juvenile Myelomonocytic Leukemia, Juvenile Xanthogranulomas and Neurofibromatosis Type 1: Case Report and Review of the Literature.
    Paulus S; Koronowska S; Fölster-Holst R
    Pediatr Dermatol; 2017 Mar; 34(2):114-118. PubMed ID: 28111791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JXG, NF1, and JMML: alphabet soup or a clinical issue?
    Burgdorf WH; Zelger B
    Pediatr Dermatol; 2004; 21(2):174-6. PubMed ID: 15078363
    [No Abstract]   [Full Text] [Related]  

  • 6. Juvenile xanthogranulomas are highly prevalent but transient in young children with neurofibromatosis type 1.
    Fenot M; Stalder JF; Barbarot S
    J Am Acad Dermatol; 2014 Aug; 71(2):389-90. PubMed ID: 25037786
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive value of café au lait macules at initial consultation in the diagnosis of neurofibromatosis type 1.
    Nunley KS; Gao F; Albers AC; Bayliss SJ; Gutmann DH
    Arch Dermatol; 2009 Aug; 145(8):883-7. PubMed ID: 19687418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic outcome in children with multiple café au lait spots.
    Korf BR
    Pediatrics; 1992 Dec; 90(6):924-7. PubMed ID: 1344978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated juvenile xanthogranuloma].
    Wollina U; Burgdorf WH; Haroske G
    J Dtsch Dermatol Ges; 2006 Jan; 4(1):45-8. PubMed ID: 16503931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAAD Grand Rounds quiz. Café-au-lait macules and enlarging papules on the face.
    Mallory M; Bryer BM; Wilson BB
    J Am Acad Dermatol; 2013 Feb; 68(2):348-50. PubMed ID: 23317978
    [No Abstract]   [Full Text] [Related]  

  • 11. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
    Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
    J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurofibromatosis type 1 diagnosed in a child based on multiple juvenile xanthogranulomas and juvenile myelomonocytic leukemia.
    Jans SR; Schomerus E; Bygum A
    Pediatr Dermatol; 2015; 32(1):e29-32. PubMed ID: 25516272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eye disorders in neurofibromatosis (NF1).
    Kordić R; Sabol Z; Cerovski B; Katusić D; Jukić T
    Coll Antropol; 2005; 29 Suppl 1():29-31. PubMed ID: 16193672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
    García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
    Actas Dermosifiliogr; 2022; 113(10):T923-T929. PubMed ID: 36162491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Juvenile xanthogranuloma, neurofibromatosis, and juvenile chronic myelogenous leukemia. World statistical analysis.
    Zvulunov A; Barak Y; Metzker A
    Arch Dermatol; 1995 Aug; 131(8):904-8. PubMed ID: 7632061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Xanthogranuloma juvenile combined with neurofibromatosis].
    Savova I; Marina S
    Vestn Dermatol Venerol; 1990; (7):71-3. PubMed ID: 2124018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous Manifestations not Considered Diagnostic Criteria for Neurofibromatosis Type 1. A Case-Control Study.
    García-Martínez FJ; Duat-Rodríguez A; Andrés Esteban E; Torrelo A; Noguera Morel L; Hernández-Martín A
    Actas Dermosifiliogr; 2022; 113(10):923-929. PubMed ID: 35636506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile xanthogranuloma and nevus anemicus in the diagnosis of neurofibromatosis type 1.
    Ferrari F; Masurel A; Olivier-Faivre L; Vabres P
    JAMA Dermatol; 2014 Jan; 150(1):42-6. PubMed ID: 24258576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neurofibromatosis type 1 complications in the pediatric age: follow-up of a hundred cases].
    Bonnemaison E; Roze-Abert B; Lorette G; Sirinelli D; Boscq M; Mazjoub S; De Courtivron B; Bonnard C; Despert F; Toutain A; Maheut-Lourmière J; Barthez MA; Castelnau P;
    Arch Pediatr; 2006 Jul; 13(7):1009-14. PubMed ID: 16716577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile xanthogranuloma with extra-cutaneous lesions--a case report.
    Cusick EL; Spicer RD
    Eur J Pediatr Surg; 1994 Dec; 4(6):368-9. PubMed ID: 7748839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.